The Risk of QTc Prolongation with Antiemetics in the Palliative Care Setting: A Narrative Review

This article reviews pharmacotherapy agents including anticholinergics, antihistamines, antidopaminergics, 5-HT3 receptor antagonists, dronabinol, and medical marijuana and their associated risk of QTc prolongation. A clinical treatment pathway is provided to help guide clinicians in choosing the most appropriate antiemetic based upon patient specific factors for QTc prolongation.PMID:33974499 | DOI:10.1080/15360288.2021.1900491
Source: Journal of Pain and Palliative Care Pharmacotherapy - Category: Palliative Care Authors: Source Type: research